line of therapy Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Phase 2 (1)
Unknown (1)

Interventional (2)
Observational (1)

Big Ten Cancer Research Consortium (1)
Hellenic Society of Medical Oncology (1)
Institut Claudius Regaud (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadimmunohistochemistry

I am/have/hadcardiac arrhythmia

I am/have/hadinterstitial lung disease

I am/have/hadulcerative

I am/have/hadHIV Infection

I am/have/hadpulmonary disease

I am/have/hadmarginal zone lymphoma

I am/have/hadautologous hematopoietic stem cell transplant

I am/have/hadcell transplantation

I am/have/hadpsychiatric disorder

I am/have/hadangina

I am/have/hadhashimoto syndrome

I am/have/hadhormone replacement

I am/have/hadheart failure

I am/have/hadcirrhosis

I am/have/hadpneumonia

I am/have/hadinvestigational treatment

I am/have/hadindolent lymphoma

I am/have/hadhair thinning

I am/have/hadarrhythmia

added new label for I am/have/had

I am looking for

I am looking forcyp3a4 inducers

I am looking forattenuated vaccines

I am looking fornivolumab

I am looking forrituximab

I am looking forhepatitis b surface antigen

I am looking forcyp3a4 inhibitors

I am looking forendocrine therapy

I am looking forprednisone

I am looking forcorticosteroids

I am looking forpi3k inhibitor

I am looking forcopanlisib

I am looking forhormone therapy

I am looking forhba1c

I am looking forimmunosuppressive agents

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor Copanlisib Given in Combination With the Immunotherapeutic Agents Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

Patients with relapsed or refractory follicular or marginal zone lymphoma who have received at least one prior line of therapy will receive Copanlisib IV: day 1, 8, 15 every 28 days Nivolumab IV: Cycle 1 days 1 and 15; then day 1 only Rituximab IV: Cycle 1 days 1, 8, …

cyp3a4 inducers

rituximab

immunohistochemistry

cardiac arrhythmia

interstitial lung disease

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Consolidative Radiotherapy Versus Observation for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

This is a phase II, multicenter, randomized open-label and comparative study designed to evaluate whether local consolidative radiotherapy improves overall survival as compared with standard management in patients with limited metastatic urothelial bladder cancer and without progression following first-line systemic therapy. Each patient will be followed during 3 years from …

2 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

reatment Standards and Outcomes of Patients With ER/PR Positive HER2-negative Metastatic Breast Cancer

To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece

stage iv breast cancer

cancer

HER2

breast cancer

0 views
19 Feb, 2024